OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
655
Results
Show all
Save search
Copy query
Show results for
Unknown
(648)
Proteomics
(3)
Transcriptomics
(2)
Genomics
(1)
Metabolomics
(1)
Organisms
Homo sapiens
(4)
Mus musculus
(2)
Repository
iProX
(3)
biostudies-arrayexpress
(2)
EGA
(1)
MetaboLights
(1)
Technology Type
Mass spectrometry
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse phase
(1)
Liquid Chromatography MS - negative - reverse phase
(1)
Publication Date
2010
(2)
2026
(1)
2023
(1)
2021
(1)
CHEBI ID
CHEBI:177942
(1)
CHEBI:180644
(1)
CHEBI:180643
(1)
CHEBI:180641
(1)
CHEBI:180640
(1)
CHEBI:180639
(1)
CHEBI:180638
(1)
CHEBI:180637
(1)
CHEBI:180636
(1)
CHEBI:180635
(1)
CHEBI:180634
(1)
CHEBI:180633
(1)
CHEBI:178691
(1)
CHEBI:180642
(1)
CHEBI:169837
(1)
CHEBI:180632
(1)
CHEBI:165451
(1)
CHEBI:174842
(1)
CHEBI:17833
(1)
CHEBI:168398
(1)
CHEBI:168736
(1)
CHEBI:175585
(1)
CHEBI:32173
(1)
CHEBI:38225
(1)
CHEBI:72952
(1)
CHEBI:141500
(1)
CHEBI:138564
(1)
CHEBI:44794
(1)
CHEBI:6722
(1)
CHEBI:16496
(1)
Metabolite Name
SUXIBUZONE
(1)
12,14-Pentacosadiynoic acid
(1)
5-b-Cholestane-3a ,7a ,12a-triol
(1)
Zanthobisquinolone
(1)
PI(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
(1)
PI(18:2(9Z,12Z)/0:0)
(1)
PI(18:3(9Z,12Z,15Z)/0:0)
(1)
Octadecanedioic acid
(1)
Calcitriol
(1)
(3beta,5alpha,6beta,24R)-Stigmastane-3,5,6-triol
(1)
Study type
Unknown experiment type
(2)
Release Date
2025
(109)
2023
(96)
2024
(91)
2022
(86)
2021
(75)
2020
(51)
2019
(30)
2018
(22)
2016
(19)
2015
(18)
2017
(16)
2026
(9)
2014
(8)
2010
(7)
2013
(5)
2012
(3)
2008
(2)
2011
(1)
2007
(1)
2005
(1)
Previous
page
1 / 66
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
66
Next
page
Sort
by:
Relevance
Page size
10
Improved Outcomes with Induction Chemotherapy Combined with Arsenic Trioxide in Stage 4 Neuroblastoma: A Case Series.
Not available
S-EPMC8485563
|
biostudies-literature
Cite
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway.
Not available
S-EPMC5225176
|
biostudies-literature
Cite
Unilateral biportal endoscopic versus microscopic transforaminal lumbar interbody fusion for degenerative lumbar spinal stenosis in China: study protocol for a prospective, randomised, controlled, non-inferiority trial.
Not available
S-EPMC11425936
|
biostudies-literature
Cite
20(S)-Ginsenoside Rh2 displays efficacy against T-cell acute lymphoblastic leukemia through the PI3K/Akt/mTOR signal pathway.
Not available
S-EPMC7471214
|
biostudies-literature
Cite
Safety and efficacy of intralesional rituximab injection versus involved site radiation therapy in primary ocular adnexal MALT lymphoma: study protocol for a multicentre randomised controlled trial.
Not available
S-EPMC11603821
|
biostudies-literature
Cite
Mechanistic insights into endometriosis: roles of Streptococcus agalactiae and L-carnitine in lesion development and angiogenesis.
Not available
S-EPMC12198069
|
biostudies-literature
Cite
A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance.
Not available
S-EPMC7738869
|
biostudies-literature
Cite
Combined Ultrasound-Guided Thoracic Paravertebral Nerve Block with Subcostal Transversus Abdominis Plane Block for Analgesia After Total Minimally Invasive Mckeown Esophagectomy: A Randomized, Controlled, and Prospective Study.
Not available
S-EPMC10036694
|
biostudies-literature
Cite
1.0 T open-configuration magnetic resonance-guided microwave ablation of pig livers in real time.
Not available
S-EPMC4551954
|
biostudies-literature
Cite
Enhancing prediction of cervical lymph node metastasis in papillary thyroid carcinoma through nodule-oriented quantification: combined S-Detect and ultrasound elastography.
Not available
S-EPMC11994488
|
biostudies-literature
Cite
Previous
page
1 / 66
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
66
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
